Current report filing

STOCKHOLDERS' INVESTMENT, EARNINGS PER SHARE AND ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS), Anti-dilutive Securities (Details)

v3.20.1
STOCKHOLDERS' INVESTMENT, EARNINGS PER SHARE AND ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS), Anti-dilutive Securities (Details) - $ / shares
7 Months Ended 12 Months Ended
Oct. 31, 2019
Mar. 31, 2019
Mar. 31, 2018
Options      
Antidilutive Securities [Abstract]      
Antidilutive securities excluded from computation of earnings per share, outstanding 3,175,849 2,490,483 2,890,140
Antidilutive securities excluded from computation of earnings per share, weighted average exercise price (in dollars per share) $ 26.58 $ 34.20 $ 38.77
Restricted Stock Awards      
Antidilutive Securities [Abstract]      
Antidilutive securities excluded from computation of earnings per share, outstanding 646,714 581,677 547,927
Antidilutive securities excluded from computation of earnings per share, weighted average exercise price (in dollars per share) $ 8.51 $ 9.33 $ 21.00